What does Polaryx Therapeutics, Inc. do?
Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination…
What is Polaryx Therapeutics, Inc.'s P/E and P/B ratio?
Polaryx Therapeutics, Inc. has a P/E ratio of -13.9 and a P/B ratio of 8.84.
What is Polaryx Therapeutics, Inc.'s debt-to-equity ratio?
Polaryx Therapeutics, Inc. has a debt-to-equity ratio of 0.00.
How much does Polaryx Therapeutics, Inc. owe compared with what it owns?
Polaryx Therapeutics, Inc. owes $0.07 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Polaryx Therapeutics, Inc.'s Positivity rank?
Polaryx Therapeutics, Inc. is ranked #1,886 of 6,774 companies globally and #485 of 4,000 in United States on PositoAI, with a Positivity Score of 22,165.
Does Polaryx Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Polaryx Therapeutics, Inc..
Where can I read the latest news about Polaryx Therapeutics, Inc.?
Recent headlines about Polaryx Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Polaryx Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Polaryx Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.